Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 19, Issue 12, Pages 1623-1635
Publisher
Informa Healthcare
Online
2015-12-22
DOI
10.1517/14728222.2015.1071354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-376a and Histone Deacetylation 9 Form A Regulatory Circuitry in Hepatocellular Carcinoma
- (2015) Yongxia Zheng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Targeting the PD-1 pathway: a promising future for the treatment of melanoma
- (2014) Andrew Mamalis et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro
- (2014) Brian I Carr et al. BMC CANCER
- Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
- (2014) Rosalba D’Alessandro et al. BMC CANCER
- Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
- (2014) Masafumi Ikeda et al. CANCER SCIENCE
- Targeted Therapies in Hepatocellular Carcinoma
- (2014) F. Bronte et al. CURRENT MEDICINAL CHEMISTRY
- Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer
- (2014) Kaipeng Xie et al. GENE
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever
- (2014) Vinicio Carloni et al. LIVER INTERNATIONAL
- The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment
- (2014) Marco D'Anzeo et al. MOLECULES
- Platelet-Related Phenotypic Patterns in Hepatocellular Carcinoma Patients
- (2014) Brian I. Carr et al. SEMINARS IN ONCOLOGY
- Methylated Cysteine Dioxygenase-1 Gene Promoter in the Serum Is a Potential Biomarker for Hepatitis B Virus-Related Hepatocellular Carcinoma
- (2014) Yang Yang et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation
- (2014) P. De Simone et al. TRANSPLANTATION PROCEEDINGS
- Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
- (2014) Chun-Jen Liu WORLD JOURNAL OF GASTROENTEROLOGY
- The role of targeted therapy for gastrointestinal tumors
- (2014) Christian Rolfo et al. Expert Review of Gastroenterology & Hepatology
- Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
- (2013) R. Wei et al. CLINICAL CANCER RESEARCH
- First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Monoclonal antibodies in gastrointestinal cancers
- (2013) Giuseppe Bronte et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?
- (2013) Valeria Amodeo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma
- (2013) Feng Li et al. GENES CHROMOSOMES & CANCER
- Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: Evidence for stromal induction of hepatocellular carcinoma
- (2013) Jocelyn H. Wright et al. INTERNATIONAL JOURNAL OF CANCER
- Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
- (2013) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
- (2013) Josep M. Llovet et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
- (2013) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects
- (2013) Motoyuki Otsuka et al. JOURNAL OF GASTROENTEROLOGY
- Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model
- (2013) Wenxiu Zhao et al. LABORATORY INVESTIGATION
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
- (2013) Chih-Hung Hsu et al. ONCOLOGY
- Quantification of Tumor DNA in Serum and Vascular Invasion of Human Hepatocellular Carcinoma
- (2013) Naoshi Nishida et al. ONCOLOGY
- DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis
- (2013) Kazuaki Nakamura et al. PLoS One
- Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
- (2012) H.-S. Shiah et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Detection of TFPI2 Methylation in the Serum of Hepatocellular Carcinoma Patients
- (2012) Feng-Kai Sun et al. DIGESTIVE DISEASES AND SCIENCES
- The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
- (2012) Lidia Rita Corsini et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics
- (2012) Evaggelia Liaskou et al. HEPATOLOGY
- Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
- (2012) Winnie Yeo et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma
- (2012) Xiaoying Zhang et al. JOURNAL OF GASTROENTEROLOGY
- Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma
- (2012) Florie Borel et al. JOURNAL OF HEPATOLOGY
- Pharmacological Unmasking Microarray Approach-Based Discovery of Novel DNA Methylation Markers for Hepatocellular Carcinoma
- (2012) Namhee Jung et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
- (2012) Armando Santoro et al. LANCET ONCOLOGY
- Paraneoplastic Thrombocytosis in Ovarian Cancer
- (2012) Rebecca L. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials
- (2012) Ping Fang et al. PLoS One
- Platelets harness the immune response to drive liver cancer
- (2012) M. K. Maini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of the myofibroblast in tumor stroma remodeling
- (2012) Marcela Otranto et al. Cell Adhesion & Migration
- The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
- (2012) Daria Capece et al. Biomed Research International
- MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?
- (2012) S Caruso et al. Oncogenesis
- Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma
- (2011) Steven Robert Alberts et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase 1/2 study of everolimus in advanced hepatocellular carcinoma
- (2011) Andrew X. Zhu et al. CANCER
- Cancer-promoting tumor-associated macrophages: New vistas and open questions
- (2011) Alberto Mantovani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors
- (2011) Gaetana Di Fede et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Targeted Therapies for Hepatocellular Carcinoma
- (2011) Augusto Villanueva et al. GASTROENTEROLOGY
- Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1
- (2011) Xiaoyong Zhang et al. HEPATOLOGY
- Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Jian Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome
- (2011) Zdenko Herceg et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
- (2010) Y Tomimaru et al. BRITISH JOURNAL OF CANCER
- Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma
- (2010) Hirotake Takai et al. CANCER BIOLOGY & THERAPY
- Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma
- (2010) L.-M. Li et al. CANCER RESEARCH
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3
- (2010) Yu Wang et al. JOURNAL OF HEPATOLOGY
- Identification of Novel Methylation Markers in Hepatocellular Carcinoma using a Methylation Array
- (2010) So Hyun Shin et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Angiogenesis in chronic liver disease and its complications
- (2010) Stephanie Coulon et al. LIVER INTERNATIONAL
- The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene
- (2010) Igor P. Pogribny et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy
- (2010) O. Khan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beyond Clotting: The Powers of Platelets
- (2010) M. Leslie SCIENCE
- Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India
- (2009) Manjula Kiran et al. CANCER GENETICS AND CYTOGENETICS
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- Hypotheses on the Role of Transforming Growth Factor-β in the Onset and Progression of Hepatocellular Carcinoma
- (2009) Steven Dooley et al. DIGESTIVE DISEASES
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation
- (2009) Daniela Carlisi et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins
- (2009) Weihong Hou et al. HEPATOLOGY
- Cellular and molecular pathways linking inflammation and cancer
- (2009) Chiara Porta et al. IMMUNOBIOLOGY
- The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines
- (2009) Brigette B.Y. Ma et al. INVESTIGATIONAL NEW DRUGS
- Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
- (2009) Marta Coscia et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
- (2009) Junfang Ji et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets
- (2008) Jin-Ping Lai et al. Future Oncology
- MicroRNA-18a Prevents Estrogen Receptor-α Expression, Promoting Proliferation of Hepatocellular Carcinoma Cells
- (2008) Wan–Hsin Liu et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage activation and polarization
- (2007) Fernando Oneissi Martinez Frontiers in Bioscience-Landmark
- Platelets Strongly Induce Hepatocyte Proliferation with IGF-1 and HGF In Vitro
- (2007) Ryota Matsuo et al. JOURNAL OF SURGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started